|
|
 |
ALUMINUM OXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACESULFAME POTASSIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ACETYLTRIBUTYL CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRDUO RESPICLICK Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AIRSUPRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ADVAIR HFA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|